Moderna, Inc. — Director's Dealing 2020

Jan 27, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-01-23

Reporting Person: Hoge Stephen (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-23	Common Stock	S	4615	$21.95	Disposed	2081915	Direct
2020-01-23	Common Stock	S	385	$22.53	Disposed	2081530	Direct
2020-01-24	Common Stock	S	5000	$21.22	Disposed	2076530	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4116	Indirect

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.47 to $22.46. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.50 to $22.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.98 to $21.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.